Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 1/20 | 0.47 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.47 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.47 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 7/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 7/20 | 0.41 |
| ▸ | RAMP3 | O60896 | 7/20 | 0.41 |
| ▸ | CALCR | P30988 | 7/20 | 0.41 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.40 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30868648 | 0.93 | IL23R (0.43) | MAPK8MAPK9MAPK10RAMP3CALCR | |
| SCHEMBL30868607 | 0.93 | RAMP3 (0.46) | MAPK8MAPK9MAPK10EPHA2OPRM1 | |
| SCHEMBL30957282 | 0.93 | EPHA2 (0.49) | MAPK8MAPK9MAPK10EPHA2OPRM1 | |
| SCHEMBL31265332 | 0.86 | ACE (0.43) | EPHA2OPRM1OPRK1 | |
| SCHEMBL29801838 | 0.86 | OPRM1 (0.52) | EPHA2OPRM1OPRK1CXCR4 | |
| SCHEMBL30868635 | 0.85 | KEAP1 (0.45) | EPHA2RAMP3CALCRCXCR4 | |
| SCHEMBL30868640 | 0.85 | NMUR2 (0.44) | MAPK8MAPK9MAPK10RAMP3CALCR | |
| SCHEMBL29905998 | 0.85 | KEAP1 (0.45) | EPHA2RAMP3CALCRCXCR4 | |
| SCHEMBL14028315 | 0.85 | RAMP3 (0.46) | RAMP3CALCR | |
| Risuteganib SCHEMBL13827707 | 0.85 | RAMP3 (0.42) | MAPK8MAPK9MAPK10RAMP3CALCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4389216-A2 | PEPTIDE COMPOSITIONS AND THERAPEUTIC USES | Allegro Pharmaceuticals, LLC (US) | 2024-06-26 | — | — | EP | disclosed |